Comparison of conventional sonographic signs and magnetic resonance imaging proton density fat fraction for assessment of hepatic steatosis

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Kim, Mimi ^a   Kang, Bo Kyeong ^a   Jun, Dae Won ^a  

^a Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; ECHOGRAPHY; FEMALE; HUMAN; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PROCEDURES; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PROGNOSIS; PROTON MAGNETIC RESONANCE SPECTROSCOPY; RETROSPECTIVE STUDIES; ROC CURVE; ULTRASONOGRAPHY;

EID: 85047254798     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-26019-x     Document Type: Article

References (36)

1. Lazo, M. & Clark, J. M. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 28, 339-350 (2008).
2. Targher, G., Day, C. P. & Bonora, E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363, 1341-1350 (2010).
3. Harrison, S. A., Torgerson, S. & Hayashi, P. H. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 98, 2042-2047 (2003).
4. Ratziu, V. et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128, 1898-1906 (2005).
5. Idilman, I. S. et al. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 267, 767-775 (2013).
6. Middleton, M. S. et al. Diagnostic Accuracy of Magnetic Resonance Imaging Hepatic Proton Density Fat Fraction in Pediatric Nonalcoholic Fatty Liver Disease. Hepatology (2017).
7. Middleton, M. S. et al. Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis. Gastroenterology 153, 753-761 (2017).
8. Kang, B. K. et al. Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard. Invest Radiol 47, 368-375 (2012).
9. Henninger, B. et al. Automated two-point dixon screening for the evaluation of hepatic steatosis and siderosis: comparison with R2-relaxometry and chemical shift-based sequences. Eur Radiol 25, 1356-1365 (2015).
10. Meisamy, S. et al. Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology 258, 767-775 (2011).
11. Caussy, C., Reeder, S. B., Sirlin, C. B. & Loomba, R. Non?invasive, quantitative assessment of liver fat by MRI?PDFF as an endpoint in NASH trials. Hepatology (2018).
12. Yokoo, T. et al. Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis. Radiology 286, 486-498 (2018).
13. Noureddin, M. et al. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology 58, 1930-1940 (2013).
14. Loomba, R. et al. Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial). Hepatology 61, 1239-1250 (2015).
15. Lee, J. Y. et al. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol 47, 239-244 (2007).
16. Ryan, C. K., Johnson, L. A., Germin, B. I. & Marcos, A. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl 8, 1114-1122 (2002).
17. Bohte, A. E., van Werven, J. R., Bipat, S. & Stoker, J. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol 21, 87-97 (2011).
18. Hernaez, R. et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 54, 1082-1090 (2011).
19. Dasarathy, S. et al. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol 51, 1061-1067 (2009).
20. Hamaguchi, M. et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 102, 2708-2715 (2007).
21. Mathiesen, U. L. et al. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis 34, 516-522 (2002).
22. Tang, A. et al. Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 274, 416-425 (2015).
23. Tang, A. et al. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 267, 422-431 (2013).
24. Imajo, K. et al. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. Gastroenterology 150, 626-637 e627 (2016).
25. Di Martino, M. et al. Comparison of magnetic resonance spectroscopy, proton density fat fraction and histological analysis in the quantification of liver steatosis in children and adolescents. World J Gastroenterol 22, 8812-8819 (2016).
26. Kutcher, R. et al. Comparison of sonograms and liver histologic findings in patients with chronic hepatitis C virus infection. J Ultrasound Med 17, 321-325 (1998).
27. Saadeh, S. et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123, 745-750 (2002).
28. Clark, J. M., Brancati, F. L. & Diehl, A. M. The prevalence and etiology of elevated aminotransferase levels in the United States. The American journal of gastroenterology 98, 960-967 (2003).
29. Takyar, V., Nath, A., Beri, A., Gharib, A. M. & Rotman, Y. How healthy are the "healthy volunteers"? Penetrance of NAFLD in the biomedical research volunteer pool. Hepatology 66, 825-833 (2017).
30. Bril, F. et al. Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients. Liver Int 35, 2139-2146 (2015).
31. Ma, X. et al. Imaging-based quantification of hepatic fat: methods and clinical applications. Radiographics 29, 1253-1277 (2009).
32. Saverymuttu, S. H., Joseph, A. E. & Maxwell, J. D. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin ResEd) 292, (13-15 (1986).
33. Lin, S. C. et al. Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique. Clin Gastroenterol Hepatol 13, 1337-1345 e1336 (2015).
34. Paige, J. S. et al. A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease. AJR Am J Roentgenol 208, W168-W177 (2017).
35. Juluri, R. et al. Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease. J Clin Gastroenterol 45, 55-58 (2011).
36. Bannas, P. et al. Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers. Hepatology 62, 1444-1455 (2015).